INTANGIBLE ASSETS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|---|
Oct. 12, 2018 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Accumulated amortization | $ (44,581) | $ (44,581) | $ (36,440) | |||
| Customer [Member] | ||||||
| Amortization expense | 8,382 | $ 67,552 | 16,672 | $ 88,337 | ||
| Intangible assets acquired fair value | 336,200 | 336,200 | ||||
| Accumulated amortization | 44,581 | $ 44,581 | ||||
| Estimated useful lives | 10 years | |||||
| Intellectual Property [Member] | ||||||
| Amortization expense | 0 | $ 295 | $ 295 | $ 589 | ||
| Impairment of intellectual property | 0 | 6,374 | ||||
| Naltrexone Implant Formulation [Member] | Australia from Trinity Compound Solutions [Member] | ||||||
| Patent acquired purchase price | $ 15,200 | |||||
| Estimated useful lives | 13 years | |||||
| Trademarks [Member] | ||||||
| Intangible assets acquired fair value | $ 249,500 | $ 249,500 | ||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of residual value of finite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes financial asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|